Pay in 4 interest-free payments of $6.98 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
In an additional, 30-week placebo-controlled, study of patients with type 2 diabetes inadequately controlled with metformin comparing the maintenance of sitagliptin 100 mg versus withdrawal of sitagliptin when initiating basal insulin therapy, the event rate and incidence of documented symptomatic hypoglycemia (blood glucose measurement 70 mg/dL) did not differ between the sitagliptin and placebo groups
Semaglutide is a medication originally developed to treat type 2 diabetes, but recently, its gained popularity for its effectiveness in promoting weight loss
The label reads 2.5 mg/mL
Early success predicts ongoing success
US$ 21.67
US$ 20.64
US$ 28.24
US$ 20.73
US$ 22.89
US$ 28.50
US$ 28.14
US$ 23.83
US$ 26.86
US$ 27.64
US$ 21.06
US$ 20.19
US$ 24.80
US$ 23.39
US$ 28.54
